Listed

Interface Inc: Form 10-Q for the period ended Sep 29, 2019

Filed with the SEC on Nov 7, 2019 and accepted by EDGAR at Nov 7, 2019, 16:26 ET.

Share

Management's discussion and analysis

As filed, 16,010 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our discussions below in this Item 2 are based upon the more detailed discussions about our business, operations and financial condition included in our Annual Report on Form 10-K for the fiscal year ended December 30, 2018, under Part II, Item 7 of that Form 10-K. Our discussions here focus on our results during the quarter and nine months ended, or as of, September 29, 2019, and the comparable periods of 2018 for comparison purposes, and, to the extent applicable, any material changes from the information discussed in that Form 10-K or other important intervening developments or information since that time. These discussions should be read in conjunction with that Form 10-K for more detailed and background information.

Forward-Looking Statements

This report contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include risks and uncertainties associated with economic conditions in the commercial interiors industry as well as the risks and uncertainties discussed under the heading “Risk Factors” included in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2018, as updated by the additional risk factor included in Part II, Item 1A of the Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, which discussions are hereby incorporated by reference. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

Acquisition of Nora Systems

On August 7, 2018, the Company completed the acquisition of nora Holding GmbH (“nora”) for a purchase price of €385.1 million, ($447.2 million at the exchange rate as of the transaction date), including acquired cash of €40.0 million ($46.5 million) for a net purchase price of €345.1 million ($400.7 million). Nora is an industry leader in the rubber flooring market, and this acquisition is expected to advance the Company’s growth strategy through a new product line and by expanding penetration into market segments outside of the office segment, particularly in healthcare, life sciences and education.

General

During the quarter ended September 29, 2019, net sales were $348.4 million compared with net sales of $318.3 million in the third quarter last year. During the first nine months of fiscal year 2019, net sales were $1,003.5 million, compared with net sales of $842.5 million in the first nine months of last year. The 2019 periods were both positively impacted by growth in LVT plus the inclusion of revenue from the nora acquisition. 2018 included revenue from the acquired nora business as of the acquisition date on August 7, 2018 through the end of the 2018 third quarter. Fluctuations in currency exchange rates had a negative impact of approximately $7.0 million for the third quarter of 2019 and a negative impact of $21.1 million for the nine-month period of 2019 compared to the three-month and nine-month periods of 2018. The 2019 three-month and nine-month periods were impacted by the weakening of the Euro, British Pound sterling and the Australian dollar against the U.S. dollar.

During the third quarter of 2019, net income was $26.2 million, or $0.45 per diluted share, compared with $8.2 million, or $0.14 per diluted share, in the third quarter last year. During the nine months ended September 29, 2019, we had net income of $62.8 million, or $1.06 per diluted share, compared with net income of $43.9 million, or $0.74 per diluted share, in the first nine months of 2018. The third quarter of 2019 and the nine-month period ended September 29, 2019 included (i) the results of the acquired nora business, and (ii) higher legal expenses related to the SEC matter discussed in Part II, Item 1 of our first quarter 2019 Form 10-Q. The 2019 periods also included amortization of acquired intangible assets of $1.3 million and $4.5 million for the three-month and nine-month periods, respectively. The 2019 nine-month period also included an income tax benefit of $3.1 million due to the remeasurement of an unrecognized tax position, which contributed to a lower tax rate for 2019. The 2018 period included the results of the acquired nora business from the acquisition date to the end of the third quarter, and related transaction expenses of $2.4 million and $8.2 million for the three-month and nine-month periods, respectively. 2018 also included $20.3 million for amortization of acquired inventory step up and intangible assets.

  • 23-

Results of Operations

The following table presents, as a percentage of net sales, certain items included in our consolidated condensed statements of operations for the three-month and nine-month periods ended September 29, 2019 and September 30, 2018, respectively:

Three Months Ended September 29, 2019 September 30, 2018 Nine Months Ended September 29, 2019 September 30, 2018
Net sales 100% 100% 100% 100%
Cost of sales 61.0 68.6 61.2 64.1
Gross profit on sales 39.0 31.4 38.8 35.9
Selling, general and administrative expenses 26.2 26.4 28.5 27.3
Restructuring charges 0.2 0.0 0.1 0.0
Operating income 12.6 5.0 10.2 8.6
Interest/Other expenses 2.2 2.0 2.2 1.7
Income before tax expense 10.4 2.9 8.0 6.9
Income tax expense 2.8 0.4 1.8 1.7
Net income 7.6 2.6 6.2 5.2

Net Sales

Below is information regarding net sales, and analysis of those results, for the three-month and nine-month periods ended September 29, 2019, and September 30, 2018, respectively.

(In thousands)

Three Months Ended September 29, 2019 September 30, 2018 Percentage Change
Net Sales $348,352 $318,325 9.4%

(In thousands)

Nine Months Ended September 29, 2019 September 30, 2018 Percentage Change
Net Sales $1,003,547 $842,514 19.1%

For the quarter ended September 29, 2019, net sales increased $30.0 million (9.4%) versus the comparable period in 2018. Included in the 2019 period were net sales from the acquired nora business. Currency fluctuations had an approximately $7.0 million (2.2)% negative impact on third quarter 2019 sales compared to the third quarter of 2018. This currency impact was mostly due to the weakening of the Euro and Australian dollar against the U.S. dollar. On a geographic basis, sales in the Americas increased 7%, Europe increased 20% and Asia-Pacific decreased 2%. The sales increase in the Americas was due primarily to the impact of the nora acquisition and growth in LVT. The sales increase in the Americas was most pronounced in the corporate office, education, and healthcare segments. The sales increase in Europe was due primarily to the impact of the nora acquisition plus growth in LVT and carpet tile. In Europe, the sales increase was, as noted, impacted by the weakening of the Euro. On a segment basis, the sales increase in Europe was most significant in the corporate office segment. The sales decrease in Asia-Pacific was primarily due to the weakening of the Australian dollar, which offset increased sales in the retail segment.

  • 24-

For the nine months ended September 29, 2019, net sales increased $161.0 million (19.1%) versus the comparable period in 2018. Included in the 2019 period were net sales from the acquired nora business. Currency fluctuations had an approximately $21.1 million (2.5)% negative impact on sales in the first nine months of 2019 compared to the first nine months of 2018. This currency impact was most pronounced in our European and Asia-Pacific operations, due to the weakening of the Euro, British Pound, and Australian dollar against the U.S. dollar. On a geographic basis, including the impact of the nora acquisition, sales for the nine-month period increased across all geographies with Americas increasing 14%, Europe increasing 34% and Asia-Pacific increasing 14%. As discussed above, the Americas sales were favorably impacted by increases in sales of our LVT product. On a segment basis, the nine-month period sales increases in the Americas were most significant in the corporate office, education, and healthcare segments, while sales in Europe were most significant in corporate office. The Asia-Pacific nine-month period sales increase was primarily in the retail segment, which was partially offset by the weakening of the Australian dollar.

Cost and Expenses

The following tables present our overall cost of sales and selling, general and administrative expenses for the three-month and nine-month periods ended September 29, 2019, and September 30, 2018, respectively:

(In thousands)

Cost and Expenses Three Months Ended September 29, 2019 September 30, 2018 Percentage Change
Cost of sales $212,590 $218,380 (2.7)%
Selling, general and administrative expenses 91,414 84,160 8.6%

(In thousands)

Cost and Expenses Nine Months Ended September 29, 2019 September 30, 2018 Percentage Change
Cost of sales $613,797 $539,839 13.7%
Selling, general and administrative expenses 286,123 230,199 24.3%

For the quarter ended September 29, 2019, cost of sales decreased $5.8 million (2.7%) compared to the third quarter of 2018. Included in the 2019 period were cost of sales for the acquired nora business and $1.3 million for the amortization of acquired intangible assets. The 2018 period included amortization of inventory step-up and intangible assets of $20.3 million related to the acquired nora business. Currency fluctuations had an approximately $1.7 million (0.8%) positive impact on the year-over-year comparison. As a percentage of sales, our cost of sales decreased to 61.0% for the third quarter of 2019 versus 68.6% for the third quarter of 2018, primarily due to the nora non-recurring inventory step-up amortization which occurred in 2018 and did not repeat in 2019.

For the nine months ended September 29, 2019, cost of sales increased $74.0 million (13.7%) versus the comparable period in 2018. Included in the first nine months of 2019 were cost of sales for the acquired nora business. Currency fluctuations had an approximately $10.5 million (2.0%) positive impact on the year-over-year comparison. Apart from the nora acquisition impacts, the increase in cost of sales for the 2019 nine-month period was due to the same factors as the nine-month period sales increase, as discussed above. As a percentage of sales, our cost of sales decreased to 61.2% for the 2019 nine-month period versus 64.1% for the comparable 2018 period, primarily due to the timing of completion of the nora acquisition and productivity initiatives.

For the quarter ended September 29, 2019, selling, general and administrative (“SG&A”) expenses increased $7.3 million (8.6%) versus the comparable period in 2018. Fluctuations in currency rates had a $0.4 million (0.5%) positive impact on the year-over-year comparison. SG&A expenses were higher for the third quarter of 2019 as the period included three months of SG&A expenses for the nora acquisition compared to 2018, which included SG&A expenses from the acquisition date on August 7, 2018 to the end of the third quarter. The higher SG&A expenses for the third quarter of 2019 were also partially due to a $1.4 million year-over-year increase in legal costs related to the SEC matter discussed in Part II, Item 1 of our first quarter 2019 Form 10-Q. These increases in SG&A expenses were partially offset by lower stock compensation expense of $1.9 million. As a percentage of sales, SG&A expenses decreased to 26.2% for the third quarter of 2019 versus 26.4% for the third quarter of 2018.

  • 25-

For the nine months ended September 29, 2019, SG&A expenses increased $55.9 million (24.3%) versus the comparable period in 2018. Included in the 2019 period were SG&A expenses for the acquired nora business. Fluctuations in currency rates had a $3.8 million (1.6%) positive impact on the year-over-year SG&A expense comparison. As discussed above, SG&A expenses are higher in the 2019 nine-month period compared to 2018 as the nora acquisition was completed during the third quarter of last year resulting in much lower SG&A expenses in the comparable 2018 period. The increase in SG&A expense was also due to higher selling expenses in the first quarter of 2019 related to bringing the Company’s global sales organization together for a meeting to accelerate the nora integration, advance our selling system transformation, and engage the sales force in the Company’s sustainability mission. The higher SG&A expenses for the nine-month period of 2019 were also partially due to a $3.7 million year-over-year increase in legal costs related to the SEC matter discussed in Part II, Item 1 of our first quarter 2019 Form 10-Q. As a percentage of sales, SG&A expenses increased to 28.5% for the nine months ended September 29, 2019, versus 27.3% for the same period in 2018.

Interest Expense

For the three-month period ended September 29, 2019, interest expense increased $1.7 million, from $4.9 million in the comparable period last year to $6.6 million. For the nine-month period ended September 29, 2019, interest expense increased $11.0 million, from $9.2 million in the comparable period last year to $20.2 million. These increases were a result of (1) additional debt incurred to complete the nora acquisition, and (2) higher average interest rates on our borrowings in the first nine months of 2019 as compared to 2018.

Liquidity and Capital Resources

General

At September 29, 2019, we had $85.2 million in cash. At that date, we had $588.0 million in term loan borrowing, $45.1 million of revolving loan borrowings and $2.5 million in letters of credit outstanding under the Syndicated Credit Facility. As of September 29, 2019, we had additional borrowing capacity of $252.4 million under the Syndicated Credit Facility and $9.4 million of borrowing capacity under other credit facilities in place at other non-U.S. subsidiaries.

Analysis of Cash Flows

We exited the quarter ended September 29, 2019 with $85.2 million in cash, an increase of $4.2 million during the first nine months of the year. The most significant factors in the increase were cash inflows from financing activities of $76.0 million from borrowings under our Syndicated Credit Facility. These inflows were partially offset by financing outflows, which included (1) $65.4 million used for repayments under our Syndicated Credit Facility, (2) $25.2 million to repurchase 1.6 million shares of the Company’s outstanding common stock, and (3) dividends paid on our common stock of $11.6 million. Cash outflows for investing activities included $53.9 million used for capital expenditures during the first nine months of 2019. Cash flows from operations in the first nine months of 2019 provided $89.9 million with net income of $62.8 million partially offset by working capital uses of cash of (1) $11.8 million for increases in inventories, (2) $4.5 million due to increases in prepaid expense and other current assets, and (3) $0.9 million due to an increase in accounts receivable. These uses of cash were partially offset by a source of cash of $11.5 million from an increase in accounts payable and accrued expenses.

Purchase Obligations

We have outstanding purchase obligations of $14.5 million related to expanding our manufacturing capabilities, which we expect to fund during the remainder of 2019.

Market risk

As filed, 2,674 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The discussion below in this Item 3 is based upon the more detailed discussions of our market risk and related matters included in our Annual Report on Form 10-K for the fiscal year ended December 30, 2018, under Part II, Item 7A of that Form 10-K. The discussion here focuses on the quarter ended September 29, 2019, and any material changes from (or other important intervening developments since the time of) the information discussed in that Form 10-K. This discussion should be read in conjunction with that Form 10-K for more detailed and background information.

For the nine months ended September 29, 2019, we recognized a $19.5 million decrease in our foreign currency translation adjustment account primarily due to the weakening of the Euro, Australian dollar and British pound against the U.S. dollar as of the end of the third quarter of 2019 compared to the end of 2018.

  • 26-

Sensitivity Analysis. For purposes of specific risk analysis, we use sensitivity analysis to measure the impact that market risk may have on the fair values of our market sensitive instruments. To perform sensitivity analysis, we assess the risk of loss in fair values associated with the impact of hypothetical changes in interest rates and foreign currency exchange rates on market sensitive instruments.

Because the debt outstanding under our Syndicated Credit Facility has variable interest rates based on an underlying prime lending rate or LIBOR rate, we do not believe changes in interest rates would have any significant impact on the fair value of that debt instrument. Changes in the underlying prime lending rate or LIBOR rate would, however, impact the amount of our interest expense. For a discussion of these hypothetical impacts on our interest expense, please see the discussion in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 30, 2018.

As of September 29, 2019, a 10% decrease or increase in the levels of foreign currency exchange rates against the U.S. dollar, with all other variables held constant, would result in a decrease in the fair value of our financial instruments of $12.3 million or an increase in the fair value of our financial instruments of $15.1 million, respectively. As the impact of offsetting changes in the fair market value of our net foreign investments is not included in the sensitivity model, these results are not indicative of our actual exposure to foreign currency exchange risk.

As of September 29, 2019, a 10% decrease or increase in the fair market value of the Company’s cash flow interest rate swaps would lead to a decrease or increase in the recorded liability values of $0.8 million.

Controls and procedures

As filed, 1,528 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was performed under the supervision and with the participation of our management, including our President and Chief Executive Officer and our Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Act”), pursuant to Rule 13a-14(c) under the Act.

No system of controls, no matter how well designed and operated, can provide absolute assurance that the objectives of the system of controls are met, and no evaluation of controls can provide absolute assurance that the system of controls has operated effectively in all cases. Our disclosure controls and procedures however are designed to provide reasonable assurance that the objectives of disclosure controls and procedures are met.

Based on the evaluation, our President and Chief Executive Officer and our Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report to provide reasonable assurance that the objectives of disclosure controls and procedures are met.

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

  • 27-

Risk factors

As filed, 338 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Part I, Item 1A, “Risk Factors,” of our annual report on Form 10-K for the year ended December 30, 2018, as supplemented by Part II, Item 1A of our quarterly report on Form 10-Q for the quarter ended March 31, 2019.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-29. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue9 months2018-12-31 to 2019-09-29$1.00bnus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2019-07-01 to 2019-09-29$212.6mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2018-12-31 to 2019-09-29$613.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-07-01 to 2019-09-29$135.8mus-gaap:GrossProfit
Gross profit9 months2018-12-31 to 2019-09-29$389.8mus-gaap:GrossProfit
Selling, general and administrative3 months2019-07-01 to 2019-09-29$91.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2018-12-31 to 2019-09-29$286.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-07-01 to 2019-09-29$43.7mus-gaap:OperatingIncomeLoss
Operating income9 months2018-12-31 to 2019-09-29$103.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-07-01 to 2019-09-29$6.6mus-gaap:InterestExpense
Interest expense9 months2018-12-31 to 2019-09-29$20.2mus-gaap:InterestExpense
Income tax3 months2019-07-01 to 2019-09-29$9.9mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2018-12-31 to 2019-09-29$17.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-07-01 to 2019-09-29$26.2mus-gaap:NetIncomeLoss
Net income9 months2018-12-31 to 2019-09-29$62.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-07-01 to 2019-09-29$0.45us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2018-12-31 to 2019-09-29$1.06us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-07-01 to 2019-09-29$0.45us-gaap:EarningsPerShareBasic
Basic EPS9 months2018-12-31 to 2019-09-29$1.06us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-07-01 to 2019-09-2958,434,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2018-12-31 to 2019-09-2959,122,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2018-12-31 to 2019-09-29$89.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2018-12-31 to 2019-09-29$53.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2018-12-31 to 2019-09-29$11.6mus-gaap:PaymentsOfDividends
Share repurchases9 months2018-12-31 to 2019-09-29$25.2mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-09-29$85.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-29$564.8mus-gaap:AssetsCurrent
Total assetsAt period end2019-09-29$1.42bnus-gaap:Assets
Current liabilitiesAt period end2019-09-29$255.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-29$1.07bnus-gaap:Liabilities
Long-term debtAt period end2019-09-29$594.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-09-29$31.8mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2019-09-29$357.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000715787-19-000035. Last ingested by Listed: Nov 12, 2026, 19:48 ET. Listed shows no prices and gives no investment advice.